Drug General Information
Drug ID
D0M0HJ
Former ID
DCL001120
Drug Name
S-18986
Drug Type
Small molecular drug
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Discontinued in Phase 2 [467644], [546269]
Therapeutic Class
Neurodegenerative
Company
Shionogi
Structure
Download
2D MOL

3D MOL

Formula
C10H12N2O2S
InChI
InChI=1S/C10H12N2O2S/c13-15(14)9-5-2-1-4-8(9)12-7-3-6-10(12)11-15/h1-2,4-5,10-11H,3,6-7H2/t10-/m1/s1
InChIKey
MNTIJYGEITVWHU-SNVBAGLBSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Glutamate receptor AMPA subtype Target Info Modulator [536166]
References
Ref 467644(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4304).
Ref 546269Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007184)
Ref 536166Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.